Diverticular Disease and Rifaximin: An Evidence-Based Review
There have been considerable advances in the treatment of diverticular disease in recent years. Antibiotics are frequently used to treat symptoms and prevent complications. Rifaximin, a non-absorbable antibiotic, is a common therapeutic choice for symptomatic diverticular disease in various countrie...
Main Authors: | Anna Piccin, Marco Gulotta, Stefano di Bella, Paola Martingano, Lory Saveria Crocè, Mauro Giuffrè |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/443 |
Similar Items
-
Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications
by: E. V. Golovanova
Published: (2019-05-01) -
STATE-OF-THE-ART: DIAGNOSIS AND TREATMENT FOR LARGE INTESTINE DIVERTICULAR DISEASE (APPROACHES AND TECHNIQUES REVIEW)
by: D. P. Puzanov, et al.
Published: (2019-02-01) -
STATE-OF-THE-ART: DIAGNOSIS AND TREATMENT FOR LARGE INTESTINE DIVERTICULAR DISEASE (APPROACHES AND TECHNIQUES REVIEW)
by: D. P. Puzanov, et al.
Published: (2019-02-01) -
Microbiota Composition in Diverticular Disease: Implications for Therapy
by: Antonio Tursi, et al.
Published: (2022-11-01) -
Treatment of diverticular disease: an update on latest evidence and clinical implications
by: Marilia Carabotti, et al.
Published: (2018-03-01)